Statements of Operations-Additional Information (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
|---|
| Income Statement Related Disclosures [Abstract] |
|
| Schedule of revenues disaggregated by major product category and geographic region |
Net Sales by Product Type | | | | | | | | | | | | | | | | | For the Year Ended June 30 | | 2026 | | 2025 | | 2024 | Animal Health | | | | | | | | | | MFAs and other | | $ | 810,728 | | $ | 646,354 | | $ | 420,959 | Nutritional specialties | | | 195,072 | | | 179,289 | | | 164,671 | Vaccines | | | 156,419 | | | 137,153 | | | 120,852 | Total Animal Health | | $ | 1,162,219 | | $ | 962,796 | | $ | 706,482 | Mineral Nutrition | | | 282,341 | | | 253,240 | | | 243,663 | Performance Products | | | 73,533 | | | 80,179 | | | 67,534 | Total | | $ | 1,518,093 | | $ | 1,296,215 | | $ | 1,017,679 |
Net Sales by Region | | | | | | | | | | | | | | | | | | | | For the Year Ended June 30 | | 2026 | | 2025 | | 2024 | United States | | $ | 877,127 | | $ | 739,919 | | $ | 584,763 | Latin America and Canada | | | 340,668 | | | 298,649 | | | 247,705 | Europe, Middle East and Africa | | | 187,942 | | | 160,232 | | | 121,977 | Asia Pacific | | | 112,356 | | | 97,415 | | | 63,234 | Total | | $ | 1,518,093 | | $ | 1,296,215 | | $ | 1,017,679 |
|
| Schedule of interest expense, net |
| | | | | | | | | | | | | | | | | | | | For the Year Ended June 30 | | 2026 | | 2025 | | 2024 | Interest expense, net | | | | | | | | | | Credit Facilities | | $ | 43,815 | | $ | 32,779 | | $ | 20,646 | 2022 Term loan | | | — | | | 12 | | | 862 | Amortization of debt issuance costs | | | 2,317 | | | 2,015 | | | 1,040 | Refinancing expense | | | — | | | 1,960 | | | — | Other | | | 284 | | | 458 | | | 462 | Interest expense | | | 46,416 | | | 37,224 | | | 23,010 | Interest income | | | (1,987) | | | (2,622) | | | (4,474) | | | $ | 44,429 | | $ | 34,602 | | $ | 18,536 |
|
| Schedule of depreciation and amortization |
| | | | | | | | | | | | | | | | | | | | For the Year Ended June 30 | | 2026 | | 2025 | | 2024 | Depreciation and amortization | | | | | | | | | | Depreciation of property, plant and equipment | | $ | 44,635 | | $ | 37,762 | | $ | 26,517 | Amortization of intangible assets | | | 6,879 | | | 7,843 | | | 9,661 | | | $ | 51,514 | | $ | 45,605 | | $ | 36,178 |
|
| Schedule of amortization of intangible assets |
| | | | For the Years Ending June 30 | | | | 2027 | | $ | 6,453 | 2028 | | | 6,245 | 2029 | | | 6,245 | 2030 | | | 4,843 | 2031 | | | 3,567 | Thereafter | | | 2,699 | Total | | $ | 30,052 |
|
| Schedule of research and development expense |
| | | | | | | | | | For the Year Ended June 30 | | 2026 | | 2025 | | 2024 | Research and development expense | | $ | 24,551 | | $ | 23,726 | | $ | 29,194 |
|